Trial for the Optimal Timing of HIV Therapy After Cryptococcal Meningitis.

Trial Profile

Trial for the Optimal Timing of HIV Therapy After Cryptococcal Meningitis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Dec 2015

At a glance

  • Drugs Antiretrovirals
  • Indications HIV infections
  • Focus Biomarker; Therapeutic Use
  • Acronyms COAT
  • Most Recent Events

    • 06 Mar 2013 Primary endpoint results presented at the 20th Conference on Retroviruses and Opportunistic Infections.
    • 06 Mar 2013 This study was halted early by the Data and Safety Monitoring Board due to a substantial excess 6-month mortality in the early ART group.
    • 06 Mar 2013 Biomarker results presented at the 20th Conference on Retroviruses and Opportunistic Infections.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top